New Zealand markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.0300-0.0400 (-0.98%)
At close: 04:00PM EDT
4.0500 +0.02 (+0.50%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-12,717
-14,287
-112,662
-37,127
-53,479
-
Depreciation & amortisation
12.799
7.052
186.445
271.677
229.61
-
Stock-based compensation
514.045
444.459
16,981
7,814
4,983
-
Change in working capital
-913.258
1,619
-1,759
-8,327
5,573
-
Accounts payable
493.934
827.463
-858.513
-2,731
2,327
-
Other working capital
-13,235
-12,271
-25,011
-37,686
-41,828
-
Other non-cash items
-
-
72,523
-
-
-
Net cash provided by operating activities
-13,134
-12,178
-25,011
-37,686
-41,803
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-93.093
-
-
-25.709
-30.901
Net cash used for investing activities
-101.071
-93.093
0
0
-25.709
-
Cash flows from financing activities
Common stock issued
16,000
5,789
682.973
1,539
0
-
Other financing activities
-1,290
-648.928
-
-
-
-
Net cash used provided by (used for) financing activities
14,710
5,140
682.973
1,747
150.949
-
Net change in cash
1,474
-7,131
-24,328
-35,939
-41,677
-
Cash at beginning of period
30,996
28,787
53,076
89,018
130,089
-
Cash at end of period
32,470
21,648
28,787
53,076
89,018
-
Free cash flow
Operating cash flow
-13,134
-12,178
-25,011
-37,686
-41,803
-
Capital expenditure
-
-93.093
-
-
-25.709
-30.901
Free cash flow
-13,235
-12,271
-25,011
-37,686
-41,828
-